KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $2.8 million.

  • Biolife Solutions' Free Cash Flow fell 2402.39% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 9221.38%. This contributed to the annual value of $5.2 million for FY2024, which is 12756.5% up from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Free Cash Flow is $2.8 million, which was down 2402.39% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Free Cash Flow ranged from a high of $6.0 million in Q2 2025 and a low of -$12.0 million during Q2 2022
  • Over the past 5 years, Biolife Solutions' median Free Cash Flow value was -$329000.0 (recorded in 2021), while the average stood at -$1.9 million.
  • Over the last 5 years, Biolife Solutions' Free Cash Flow had its largest YoY gain of 24568.38% in 2022, and its largest YoY loss of 948000.0% in 2022.
  • Biolife Solutions' Free Cash Flow (Quarter) stood at -$2.3 million in 2021, then skyrocketed by 245.68% to $3.4 million in 2022, then tumbled by 60.99% to $1.3 million in 2023, then plummeted by 33.61% to $883000.0 in 2024, then skyrocketed by 217.33% to $2.8 million in 2025.
  • Its Free Cash Flow was $2.8 million in Q3 2025, compared to $6.0 million in Q2 2025 and $1.2 million in Q1 2025.